case_images: PMC10883690_01
case_images: There is diffuse peripancreatic inflammation and edema. There is presence of prominent mesenteric edema within the lesser sac of the omentum and anterior aspect of the mesentery. Mild free fluid is present in the pelvis.
case_images: cro-2024-0017-0001-533904_F01.jpg
case_images: PMC10883690_01_cro-2024-0017-0001-533904_F01.jpg
case_images: F1
case_images: CT abdomen and pelvis, as seen in Figure 1, displayed diffuse peripancreatic inflammation and edema, which was consistent with acute pancreatitis.
case_images: a Patients lipid panel trend since 2021 to current. The patient's lipid panel was drawn on April 28, 2021, and the patient was started on pembrolizumab and lenvatinib on March 31, 2021. b Patients triglyceride level 312 on April 28, 2021, with a peak of greater than 2,000 in 2022 on the date of admission to the hospital for hypertriglyceridemia-induced pancreatitis. Patient was started on pembrolizumab and lenvatinib on March 31, 2021.
case_images: cro-2024-0017-0001-533904_F02.jpg
case_images: PMC10883690_01_cro-2024-0017-0001-533904_F02.jpg
case_images: F2
case_images: Patients' lipid profile over time is depicted in Figure 2a with patients triglyceride levels depicted over the course of time in Figure 2b.